Search

everythinglearnresearchcommunity

for

Search:↓

New insights into cell communication in psoriasis suggest innovative drug treatments.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Over 150 new molecules with biological activities were found in traditional herbal medicines, some with potential for new drug development.

The African spiny mouse can fully regenerate its muscle without scarring, unlike the common house mouse.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Retinoids and narrowband UVB phototherapy are effective for treating psoriasis and can reduce treatment time when used together.

Certain proteins, caspases-1 and -11, are important in the early development of skin inflammation in mice.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Burn scars heal abnormally and more research is needed to find better treatments.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

Fish oil improves skin health in people with diabetes and high cholesterol.

Targeting specific cell interactions may help treat skin fibrosis.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

The immune system plays a key role in tissue repair, affecting both healing quality and regenerative ability.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

Children with atopic dermatitis often have sleep problems due to itching and may benefit from melatonin, which helps with sleep and skin symptoms.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.